O14746 (TERT_HUMAN) Homo sapiens (Human)
Telomerase reverse transcriptase UniProtKBInterProSTRINGInteractive Modelling
1132 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; )
It is possible new templates exist for this target since these models were created.
Sequence Features
| 712 | Magnesium; catalytic | ||
| 868 | Magnesium; catalytic | ||
| 869 | Magnesium; catalytic | ||
| 169 | Required for optimal binding of telomeric ssDNA and incorporation of nucleotides at the second position of the template | ||
| 867 | Required for nucleotide incorporation and primer extension rate | ||
| 55 | L -> Q (in idiopathic pulmonary fibrosis susceptibility; impaired telomerase activity; dbSNP:rs387907247) VAR_062535 dbSNP | ||
| 65 | P -> A (associated with acute myeloid leukemia; dbSNP:rs544215765) VAR_062780 dbSNP | ||
| 170 | V -> M (in PFBMFT1; the mutant protein is demonstrated to cause decreased telomerase activity; dbSNP:rs387907248) VAR_068792 dbSNP | ||
| 202 | A -> T (in PFBMFT1 and AA; severe and moderate; associated with disease susceptibility; shorter telomeres; dbSNP:rs121918661) VAR_036863 dbSNP | ||
| 279 | A -> T (in dbSNP:rs61748181) VAR_036864 dbSNP | ||
| 299 | V -> M (associated with acute myeloid leukemia; dbSNP:rs756624928) VAR_062781 dbSNP | ||
| 412 | H -> Y (in PFBMFT1, AA and DKCB4; severe and moderate; associated with susceptibility to acute myelogenous leukemia; the mutant protein has 36% residual activity; dbSNP:rs34094720) VAR_025149 dbSNP | ||
| 441 | Missing (in AA; associated with susceptibility to acute myeloid leukemia) VAR_036865 | ||
| 522 | R -> K (associated with acute myeloid leukemia) VAR_062782 | ||
| 570 | K -> N (in AA; abolishes telomerase catalytic activity but no effect on binding to TERC) VAR_062536 | ||
| 631 | R -> Q (in AA; dbSNP:rs199422294) VAR_062783 dbSNP | ||
| 682 | G -> D (in AA; non-severe; abolishes telomerase catalytic activity but little effect on binding to TERC; dbSNP:rs199422295) VAR_062537 dbSNP | ||
| 694 | V -> M (in PFBMFT1 and AA; moderate; dbSNP:rs121918662) VAR_036866 dbSNP | ||
| 704 | P -> S (in DKCB4; the mutant protein has 13% residual activity; dbSNP:rs199422297) VAR_068793 dbSNP | ||
| 716 | A -> T (in PFBMFT1; the mutant protein is demonstrated to cause severely compromised telomerase activity; dbSNP:rs387907249) VAR_068794 dbSNP | ||
| 721 | P -> R (in DKCB4; no effect on telomerase catalytic activity and little effect on binding to TERC; dbSNP:rs199422299) VAR_062538 dbSNP | ||
| 726 | T -> M (in AA; very severe; no effect on telomerase catalytic activity but shortened telomeres; dbSNP:rs149566858) VAR_062539 dbSNP | ||
| 772 | Y -> C (in PFBMFT1; moderate; dbSNP:rs121918663) VAR_036867 dbSNP | ||
| 785 | P -> L (in AA; dbSNP:rs483352771) VAR_062784 dbSNP | ||
| 791 | V -> I (in PFBMFT1; associated with Met-867 in cis on the same allele; the double mutant shows severe defects in telomere repeat addition processivity; dbSNP:rs141425941) VAR_068795 dbSNP | ||
| 811 | R -> C (in DKCB4; 50% reduction in telomerase activity; dbSNP:rs199422301) VAR_062540 dbSNP | ||
| 841 | L -> F (in PFBMFT1) VAR_068796 | ||
| 865 | R -> H (in PFBMFT1; dbSNP:rs121918666) VAR_036868 dbSNP | ||
| 867 | V -> M (in PFBMFT1; associated with Ile-791 in cis on the same allele; the double mutant shows severe defects in telomere repeat addition processivity; this mutation causes most if not all of the functional defects; dbSNP:rs201159197) VAR_068797 dbSNP | ||
| 901 | R -> W (in DKCB4; severe phenotype overlapping with Hoyeraal-Hreidarsson syndrome; very short telomeres and greatly reduced telomerase activity; dbSNP:rs199422304) VAR_062541 dbSNP | ||
| 902 | K -> N (in DKCA2; abolishes telomerase catalytic activity but no effect on binding to TERC; dbSNP:rs121918665) VAR_036869 dbSNP | ||
| 902 | K -> R (in PFBMFT1; dbSNP:rs387907250) VAR_068798 dbSNP | ||
| 923 | P -> L (in PFBMFT1; dbSNP:rs387907251) VAR_068799 dbSNP | ||
| 948 | S -> R (in dbSNP:rs34062885) VAR_053726 dbSNP | ||
| 979 | R -> W (in DKCA2; shortened telomeres but no effect on telomerase catalytic activity nor on binding to TERC; dbSNP:rs199422305) VAR_062542 dbSNP | ||
| 1025 | V -> F (in PFBMFT1) VAR_068800 | ||
| 1062 | A -> T (increased incidence in sporadic acute myeloid leukemia; dbSNP:rs35719940) VAR_025150 dbSNP | ||
| 1090 | V -> M (in PFBMFT1; severe; dbSNP:rs121918664) VAR_036870 dbSNP | ||
| 1110 | T -> M (in idiopathic pulmonary fibrosis susceptibility; impaired telomerase activity; dbSNP:rs199422306) VAR_062543 dbSNP | ||
| 1127 | F -> L (in DKCA2; severe; shortened telomeres but no effect on telomerase catalytic activity nor on binding to TERC; dbSNP:rs1176273130) VAR_062544 dbSNP | ||
| 460-591 | Telomerase ribonucleoprotein complex - RNA-binding domain IPR021891PF12009 | ||
| 817-905 | Reverse transcriptase domain IPR000477PF00078 |
Sequence Alignments
Experimental structures
| Description | Oligo-state | Ligands | Structure | Range |
|---|---|---|---|---|
| The crystal structure of human Importin alpha 5 with TERT NLS peptide |
Heteromer P52294; | 4b18 | ||
| Assess | ||||
| Human Leukocyte Antigen presenting ILGKFLHRL |
Heteromer P04439; P61769; | 15×EDO; 4×GOL; 2×SO4; | 5meo | |
| Assess | ||||
| Human Leukocyte Antigen A02 presenting ILAKFLHEL |
Heteromer P04439; P61769; | 10×EDO; 1×CA; 2×MES; 3×SO4; 1×GOL; | 5mer | |
| Assess | ||||
| Human Leukocyte Antigen A02 presenting ILAKFLHTL |
Heteromer P04439; P61769; | 1×SO4; 1×EDO; | 5meq | |
| Assess | ||||
| Human Leukocyte Antigen A02 presenting ILGKFLHWL |
Heteromer P04439; P61769; | 6×EDO; 1×SO4; | 5mep | |
| Assess | ||||
| TCR-peptide specificity overrides affinity enhancing TCR-MHC interactions |
Heteromer H2RG00; K7N5N2; P01850; P04439; P61769; | 1×GOL; 2×EDO; | 4mnq | |
| Assess | ||||
| Crystal Structure of HLA-A*2402 Complexed with a telomerase peptide |
Heteromer P04439; P61769; | 5×SO4; 2×GOL; | 2bck | |
| Assess | ||||
| Human Leukocyte Antigen A02 presenting ILAKFLHWL, in complex with cognate T-Cell Receptor |
Heteromer P04439; P61769; | 5×EDO; 1×GOL; 5×SO4; | 5men | |
| Assess | ||||
| STRUCTURE OF THE HUMAN TELOMERASE THUMB DOMAIN | monomer | 2×GSH; | 5ugw | |
| Assess | ||||
Homology models
| Oligo-state | QMEAN | Template | Range | Seq id (%) | Ligands |
|---|---|---|---|---|---|
| monomer | -3.41 | 4lmo.3.A | 39.18 | ||
| Assess | |||||
Homology models built on isoform sequence
| Isoform | Oligo-state | Ligands | QMEAN | Template | Range | Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | monomer | -4.08 | 4lmo.3.A | 39.18 | ||
| Assess | ||||||
| Isoform 3 | monomer | -3.41 | 4lmo.3.A | 39.18 | ||
| Assess | ||||||
| Isoform 4 | monomer | -4.10 | 4lmo.3.A | 39.18 | ||
| Assess | ||||||